{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:24:29Z","timestamp":1783103069299,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H160005"],"award-info":[{"award-number":["LQ23H160005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000003"],"award-info":[{"award-number":["82000003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.intimp.2026.116677","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:13:54Z","timestamp":1776788034000},"page":"116677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Kumatakenin drives renal and hepatic fibrosis via macrophage-to-myofibroblast transition"],"prefix":"10.1016","volume":"180","author":[{"given":"Shihong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116677_bb0005","doi-asserted-by":"crossref","unstructured":"C.P. Kovesdy, Epidemiology of chronic kidney disease: an update 2022, Kidney Int. Suppl. (2011) 12(1) (2022)7\u201311.","DOI":"10.1016\/j.kisu.2021.11.003"},{"issue":"2","key":"10.1016\/j.intimp.2026.116677_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212184","article-title":"Quality of life and its predictors among patients with chronic kidney disease: a hospital-based cross sectional study","volume":"14","author":"Kefale","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2026.116677_bb0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1590\/S1807-59322011000600012","article-title":"Quality of life in patients with chronic kidney disease","volume":"66","author":"Cruz","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"11","key":"10.1016\/j.intimp.2026.116677_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207960","article-title":"Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England","volume":"13","author":"Nguyen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116677_bb0025","doi-asserted-by":"crossref","first-page":"9609266","DOI":"10.1155\/2023\/9609266","article-title":"The growing challenge of chronic kidney disease: an overview of current knowledge","volume":"2023","author":"Borg","year":"2023","journal-title":"Int. J. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease -Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.intimp.2026.116677_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102203","article-title":"Chronic kidney disease progression-a challenge","volume":"12","author":"Maringhini","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.intimp.2026.116677_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116677_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13071881","article-title":"Fibrosis in chronic kidney disease: pathophysiology and therapeutic targets","volume":"13","author":"Reiss","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2026.116677_bb0060","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1172\/JCI200524282C1","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2026.116677_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"10127","key":"10.1016\/j.intimp.2026.116677_bb0070","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0075","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1038\/s41467-022-34241-5","article-title":"Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context","volume":"13","author":"Setten","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2026.116677_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109060","article-title":"Towards a unified approach in autoimmune fibrotic signalling pathways","volume":"24","author":"Sisto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1535370215597194","article-title":"Epithelial-mesenchymal transition: an emerging target in tissue fibrosis","volume":"241","author":"Li","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2026.116677_bb0090","doi-asserted-by":"crossref","first-page":"1461919","DOI":"10.3389\/fimmu.2024.1461919","article-title":"Advances in macrophage-myofibroblast transformation in fibrotic diseases","volume":"15","author":"Ban","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41420-024-02247-1","article-title":"Macrophages in organ fibrosis: from pathogenesis to therapeutic targets","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.116677_bb0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2478\/jtim-2023-0105","article-title":"FOSL2 participates in renal fibrosis via SGK1 - mediated epithelialmesenchymal transition of proximal tubular epithelial cells","volume":"11","author":"Liu","year":"2023","journal-title":"J. Transl. Int. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s42003-025-07735-3","article-title":"EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis","volume":"8","author":"Xia","year":"2025","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116677_bb0115","article-title":"METTL3 potentiates m2 macrophage-driven MMT to aggravate renal allograft fibrosis via the TGF-beta1\/Smad3 pathway","volume":"12","author":"Yao","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.intimp.2026.116677_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150783","article-title":"Macrophage erythropoietin signaling promotes macrophage-myofibroblast transformation and fibroblast-myofibroblast differentiation","volume":"734","author":"Wu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0125","first-page":"62","article-title":"Breaking boundaries: chronic diseases and the frontiers of immune microenvironments","volume":"1","author":"Li","year":"2025","journal-title":"Med. Res."},{"issue":"15","key":"10.1016\/j.intimp.2026.116677_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116677_bb0135","doi-asserted-by":"crossref","unstructured":"D.J. Nikolic-Paterson, S. Wang, H.Y. Lan, Macrophages promote renal fibrosis through direct and indirect mechanisms, Kidney Int. Suppl. (2011) 4(1) (2014)34\u201338.","DOI":"10.1038\/kisup.2014.7"},{"issue":"12","key":"10.1016\/j.intimp.2026.116677_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14121141","article-title":"Personalized antifibrotic therapy in CKD progression","volume":"14","author":"Delrue","year":"2024","journal-title":"J. Pers Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116677_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116677_bb0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2026.116677_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106223","article-title":"Supplementary kumatakenin prevents esophagus cancer progression by blocking TRIM65-FASN axis-mediated metabolic reprogramming","volume":"117","author":"Zhang","year":"2024","journal-title":"J. Funct. Foods"},{"issue":"3","key":"10.1016\/j.intimp.2026.116677_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8030350","article-title":"Phytochemicals targeting VEGF and VEGF-related multifactors as anticancer therapy","volume":"8","author":"Parveen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116677_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1127931","article-title":"Kumatakenin inhibited iron-ferroptosis in epithelial cells from colitis mice by regulating the Eno3-IRP1-axis","volume":"14","author":"Arenbaoligao","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"36","key":"10.1016\/j.intimp.2026.116677_bb0170","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1021\/acs.jafc.7b01543","article-title":"Effect of kumatakenin isolated from cloves on the apoptosis of cancer cells and the alternative activation of tumor-associated macrophages","volume":"65","author":"Woo","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.116677_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177688","article-title":"Kumatakenin alleviates depressive-like behaviors by suppressing excessive autophagy in hippocampus via ATG5","volume":"999","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116677_bb0180","first-page":"658","article-title":"Flavonoids from siparuna cristata as potential inhibitors of SARS-CoV-2 replication","volume":"31","author":"Leal","year":"2021","journal-title":"Rev. Bras"},{"issue":"9","key":"10.1016\/j.intimp.2026.116677_bb0185","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"issue":"7841","key":"10.1016\/j.intimp.2026.116677_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2026.116677_bb0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116677_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167142","article-title":"Rabeprazole mitigates obesity-induced chronic inflammation and insulin resistance associated with increased m2-type macrophage polarization","volume":"1870","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.intimp.2026.116677_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123755","article-title":"Targeting interferon regulatory factor 7 alleviates renal fibrosis by inhibiting macrophage-to-myofibroblast transition","volume":"376","author":"Ren","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116677_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.940716","article-title":"Pharmacological inhibition of STING \/ TBK1 signaling attenuates myeloid fibroblast activation and macrophage to myofibroblast transition in renal fibrosis","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11011-024-01527-0","article-title":"Jaranol alleviates cognitive impairment in db\/db mice through the PI3K\/AKT pathway","volume":"40","author":"Qian","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/lam.13084","article-title":"Synergistic antibacterial effects of buddleja albiflora metabolites with antibiotics against listeria monocytogenes","volume":"68","author":"Zhang","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0225","doi-asserted-by":"crossref","first-page":"20221030","DOI":"10.1515\/biol-2022-1030","article-title":"Inhibition of mast cell activation by jaranol-targeted pirin ameliorates allergic responses in mouse allergic rhinitis","volume":"20","author":"Huang","year":"2025","journal-title":"Open Life Sci"},{"issue":"3","key":"10.1016\/j.intimp.2026.116677_bb0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116677_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2015.01.012","article-title":"Antivascular and anti-parasite activities of natural and hemisynthetic flavonoids from new caledonian gardenia species (rubiaceae)","volume":"93","author":"Mai","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2026.116677_bb0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/db23-0700","article-title":"Macrophage SHP2 deficiency alleviates diabetic nephropathy via suppression of MAPK \/ NF-\u03baB - dependent inflammation","volume":"73","author":"Han","year":"2024","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.intimp.2026.116677_bb0245","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41467-025-67373-5","article-title":"Tracing the origin of myofibroblasts in kidney fibrosis","volume":"17","author":"He","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.116677_bb0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116677_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052664","article-title":"Tamoxifen exerts anticancer effects on pituitary adenoma progression via inducing cell apoptosis and inhibiting cell migration","volume":"23","author":"Lv","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:06:43Z","timestamp":1783102003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S1567576926005229"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116677","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kumatakenin drives renal and hepatic fibrosis via macrophage-to-myofibroblast transition","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116677"}}